ArticleCell cycle (Georgetown, Tex.)2016

Efficacy of poly (ADP-ribose) polymerase inhibitor olaparib against head and neck cancer cells: Predictions of drug sensitivity based on PAR-p53-NF-κB interactions.

Minsu Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.